Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2016 1
2017 1
2018 1
2019 3
2020 2
2021 4
2022 4
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Innate immune mechanisms of mRNA vaccines.
Verbeke R, Hogan MJ, Loré K, Pardi N. Verbeke R, et al. Immunity. 2022 Nov 8;55(11):1993-2005. doi: 10.1016/j.immuni.2022.10.014. Immunity. 2022. PMID: 36351374 Free PMC article. Review.
mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability.
Schoenmaker L, Witzigmann D, Kulkarni JA, Verbeke R, Kersten G, Jiskoot W, Crommelin DJA. Schoenmaker L, et al. Among authors: verbeke r. Int J Pharm. 2021 May 15;601:120586. doi: 10.1016/j.ijpharm.2021.120586. Epub 2021 Apr 9. Int J Pharm. 2021. PMID: 33839230 Free PMC article. Review.
The dawn of mRNA vaccines: The COVID-19 case.
Verbeke R, Lentacker I, De Smedt SC, Dewitte H. Verbeke R, et al. J Control Release. 2021 May 10;333:511-520. doi: 10.1016/j.jconrel.2021.03.043. Epub 2021 Mar 30. J Control Release. 2021. PMID: 33798667 Free PMC article. Review.
Immunopeptidomics-based design of mRNA vaccine formulations against Listeria monocytogenes.
Mayer RL, Verbeke R, Asselman C, Aernout I, Gul A, Eggermont D, Boucher K, Thery F, Maia TM, Demol H, Gabriels R, Martens L, Bécavin C, De Smedt SC, Vandekerckhove B, Lentacker I, Impens F. Mayer RL, et al. Among authors: verbeke r. Nat Commun. 2022 Oct 14;13(1):6075. doi: 10.1038/s41467-022-33721-y. Nat Commun. 2022. PMID: 36241641 Free PMC article.
Considerations on the Design of Lipid-based mRNA Vaccines Against Cancer.
Meulewaeter S, Zhang Y, Wadhwa A, Fox K, Lentacker I, Harder KW, Cullis PR, De Smedt SC, Cheng MHY, Verbeke R. Meulewaeter S, et al. Among authors: verbeke r. J Mol Biol. 2024 Jan 15;436(2):168385. doi: 10.1016/j.jmb.2023.168385. Epub 2023 Dec 6. J Mol Biol. 2024. PMID: 38065276 Review.
mRNA in cancer immunotherapy: beyond a source of antigen.
Van Hoecke L, Verbeke R, Dewitte H, Lentacker I, Vermaelen K, Breckpot K, Van Lint S. Van Hoecke L, et al. Among authors: verbeke r. Mol Cancer. 2021 Mar 3;20(1):48. doi: 10.1186/s12943-021-01329-3. Mol Cancer. 2021. PMID: 33658037 Free PMC article. Review.
Transport by circulating myeloid cells drives liposomal accumulation in inflamed synovium.
Deprez J, Verbeke R, Meulewaeter S, Aernout I, Dewitte H, Decruy T, Coudenys J, Van Duyse J, Van Isterdael G, Peer D, van der Meel R, De Smedt SC, Jacques P, Elewaut D, Lentacker I. Deprez J, et al. Among authors: verbeke r. Nat Nanotechnol. 2023 Nov;18(11):1341-1350. doi: 10.1038/s41565-023-01444-w. Epub 2023 Jul 10. Nat Nanotechnol. 2023. PMID: 37430039
22 results